Vertex Pharmaceuticals Total Liabilities and Share Holders Equity 2010-2025 | VRTX
Vertex Pharmaceuticals total liabilities and share holders equity for the quarter ending March 31, 2025 was $22.881B, a 4.34% decline year-over-year.
- Vertex Pharmaceuticals total liabilities and share holders equity for 2024 was $22.533B, a 0.87% decline from 2023.
- Vertex Pharmaceuticals total liabilities and share holders equity for 2023 was $22.73B, a 25.23% increase from 2022.
- Vertex Pharmaceuticals total liabilities and share holders equity for 2022 was $18.151B, a 35.13% increase from 2021.